Mode
Text Size
Log in / Sign up
N/A N=112 Randomized Double-blind

The Effects of Caffeinated Coffee on Intraocular Pressure

Primary Open Angle Glaucoma

Enrolled (actual)
112
Serious AEs
0.0%
Results posted
Oct 2012
Primary outcome: Primary: Change in Intraocular Pressure at 60 Minutes — 1.51; 0.52 mm Hg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Caffeinated Coffee (Other); Decaffeinated Coffee (Other)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
Massachusetts Eye and Ear Infirmary
Primary completion
Aug 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Intraocular Pressure at 60 Minutes
1.51; 0.52
PRIMARY
Change in Intraocular Pressure at 90 Minutes
1.46; 0.40

Summary

High intraocular pressure (IOP) is a known risk factor for developing primary open-angle glaucoma (POAG). There is controversy in the literature regarding the degree to which caffeine influences IOP, with some studies reporting minimal changes in IOP while others report up to 4 mmHg increases. To date there are no double-masked randomized controlled trials that examine acute caffeinated coffee's effects on IOP in patients with or at risk for primary open-angle glaucoma. The investigators aim to better understand the relationship between acute caffeinated coffee (vs decaffeinate coffee) consumption and IOP in a double-masked, crossover randomized controlled clinical trial.

Eligibility Criteria

Inclusion Criteria

  • 40-89 yrs
  • POAG for cases or no forms of glaucoma for controls
  • Willingness to drink coffee
  • Consent signed

Exclusion Criteria

  • Age less than 40 or greater than 89 yrs
  • all forms of glaucoma other than POAG
  • any condition inappropriate for tonometry (ie corneal disease, LASIK)
  • unable or unwilling to give consent
  • unable or unwilling to drink coffee
  • pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01364207). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search